SEMG1: A Potential Drug Target for Cancer (G6406)

Target Name: SEMG1

NCBI ID: G6406

SEMG1

SEMG1: A Potential Drug Target for Cancer

SEMG1 (FLJ78262) is a protein that is expressed in various tissues of the body, including the brain, heart, and blood vessels. Its primary function is to regulate the structure and function of actin filaments, which are a type of protein that plays a critical role in the mechanical properties of cells. SEMG1 has also been shown to be involved in the regulation of cell migration and the development of cancer.

SEMG1 has been identified as a potential drug target due to its involvement in several important cellular processes. For example, SEMG1 has been shown to play a role in the regulation of actin filament dynamics, which are critical for the proper functioning of many cellular processes. SEMG1 has also been shown to be involved in the regulation of cell adhesion, which is critical for the maintenance of tissue structure and the development of tissues.

In addition to its role in cellular processes, SEMG1 has also been shown to play a role in the development of cancer. For example, studies have shown that SEMG1 is often overexpressed in many types of cancer, which suggests that it may be a useful biomarker for the diagnosis and treatment of these diseases.

SEMG1 has also been shown to be involved in the regulation of many different cellular processes, including cell division, cell migration, and cell adhesion. Its primary function is to regulate the structure and function of actin filaments, which are a type of protein that plays a critical role in the mechanical properties of cells. SEMG1 has also been shown to be involved in the regulation of cell signaling pathways, which are critical for the proper functioning of many cellular processes.

SEMG1 has been shown to play a role in the regulation of actin filament dynamics, which are critical for the proper functioning of many cellular processes. SEMG1 has also been shown to be involved in the regulation of cell adhesion, which is critical for the maintenance of tissue structure and the development of tissues.

In addition to its role in cellular processes, SEMG1 has also been shown to play a role in the development of cancer. Studies have shown that SEMG1 is often overexpressed in many types of cancer, which suggests that it may be a useful biomarker for the diagnosis and treatment of these diseases.

Overall, SEMG1 is a protein that has been shown to play a critical role in a variety of cellular processes. Its functions include regulating actin filament dynamics, cell adhesion, and cell signaling pathways. As a result, SEMG1 has been identified as a potential drug target and may be a useful biomarker for the diagnosis and treatment of many types of cancer.

Protein Name: Semenogelin 1

Functions: Predominant protein in semen. It participates in the formation of a gel matrix entrapping the accessory gland secretions and ejaculated spermatozoa. Fragments of semenogelin and/or fragments of the related proteins may contribute to the activation of progressive sperm movements as the gel-forming proteins are fragmented by KLK3/PSA

The "SEMG1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEMG1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets